Key result
Early postmenopausal women demonstrated the most significant decline in flow-mediated dilation following ischemia-reperfusion injury compared to other menopausal stages.
Why the study?
In postmenopausal women, reduced ovarian function precedes endothelial dysfunction and attenuated endothelial resistance to ischemia-reperfusion (IR) injury.
Does menopausal stage affect endothelial resistance (measured by flow-mediated dilation) to ischemia-reperfusion injury in healthy women?
Cross-Sectional (n=33)
Does menopausal stage affect endothelial resistance (measured by flow-mediated dilation) to ischemia-reperfusion injury in healthy women?
Early postmenopausal women exhibit a significant attenuation in endothelial resistance to ischemia-reperfusion injury compared to premenopausal women, despite maintaining similar baseline endothelial function.
Answers are grounded in this paper and cite their sources.
Baseline FMD differs by menopausal stage and declines after IR injury; leaves open whether timing modulates endothelial protection.
BACKGROUND: In postmenopausal women, reduced ovarian function precedes endothelial dysfunction and attenuated endothelial resistance to ischemia-reperfusion (IR) injury. We hypothesized that IR injury would lower endothelial function, with premenopausal women demonstrating the greatest protection from injury, followed by early, then late postmenopausal women. METHODS: Flow-mediated dilation (FMD) was assessed at baseline and following IR injury in premenopausal (n = 11), early (n = 11; 4 ± 1.6 years since menopause), and late (n = 11; 15 ± 5.5 years since menopause) postmenopausal women. RESULTS: There were significant group differences in baseline FMD (p = 0.007); post hoc analysis revealed a similar resting FMD between premenopausal (7.8% ± 2.1%) and early postmenopausal (7.1% ± 2.7%), but significantly lower FMD in late postmenopausal women (4.5% ± 2.3%). Results showed an overall decline in FMD after IR injury (p < 0.001), and a significant condition*time interaction (p = 0.048), with early postmenopausal women demonstrating the most significant decline in FMD following IR. CONCLUSION: Our findings indicate that endothelial resistance to IR injury is attenuated in healthy early postmenopausal women.
No takes yet. Share an insight, caveat, or question.
Spicuzza et al. (2023) conducted a cross-sectional in Healthy (n=33). Early and late postmenopausal stages vs. Premenopausal stage was evaluated on Flow-mediated dilation (FMD) following ischemia-reperfusion injury (p=0.048). Early postmenopausal women demonstrated the most significant decline in flow-mediated dilation following ischemia-reperfusion injury compared to other menopausal stages.
Synapse has enriched 10 related papers. Consider them for comparative context: